1World Health Organization (WHO). National cancer control Pro- grammers policies and managerial guidelines[ M ]. Health & Devel- ovment Networks.2002 : 17.
2Sloan JA, Aaronson N, Cappelleri JC, et al. Assessing the clinical significance of single items relative to summated scores I J ]- May- oClinProe ,2002,77 (5) :479 - 487.
3Koller M, Heitmann K, Kussmann J, et al. Symptom reporting in Cancer Patients lI : relations to social desirability, negative affect, and Self - reported health behaviors [ J ]. Cancer, 1999,86 ( 8 ) : 1609 - 1620.
4Frost MH, Bonomi AE, Ferrans CE, eta/. Patient, clinician, and population porspectives on determining the clinical significance of Quality - of - life scores [ J ]. MayoClinProe, 2002,77 ( 5 ) : 488 - 494.
5Cella DF,Tulsky, DS,Gray G,et al. The functional assessment of eancertherapy scale: Develop -ment and validation of the general measure[ J ]. J ClinOneol,2002,11 : 570 - 579.
6Edeiman S, Lemon J, Bell DR,et a/. Effects of group CBT on the survival time of patients with metastatic breast cancer [ J ]. Psy- chooncoloav. ! 999.8 ( 6 ) :474 - 481.
7邱忠玉.心理干预对肺癌化疗患者身心及免疫功能影响的研究[D].长春:吉林大学,2009.
8Thomas EM, Weiss SM. Nonpharmacologieal interventions with chronic cancer Pain in adults [ J ]. Cancer Conrtol, 2000,7 (2) : 157 - 164.
9Jaeknow DS ,Tsehann JM, Link MP,et al. Hypnosis in the preven- tion of chemotherapy - related nausea and vomiting in ehildren:a prospective study [ J ]. J Dev Behav P-diatr, 1994,15 ( 4 ) : 258 - 264.
